![]() |
|
|
Vol. 18, Issue 2, 380-393, February 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2c Is Required for Efficient Sorting and Juxtacrine Function
Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, 37007 Salamanca, Spain
Submitted June 9, 2006;
Revised November 3, 2006;
Accepted November 6, 2006
Monitoring Editor: Carl-Henrik Heldin
The neuregulins (NRGs) play important roles in animal physiology, and their disregulation has been linked to diseases such as cancer or schizophrenia. The NRGs may be produced as transmembrane proteins (proNRGs), even though they lack an N-terminal signal sequence. This raises the question of how NRGs are sorted to the plasma membrane. It is also unclear whether in their transmembrane state, the NRGs are biologically active. During studies aimed at solving these questions, we found that deletion of the extracellular juxtamembrane region termed the linker, decreased cell surface exposure of the mutant proNRG
Linker, and caused its entrapment at the cis-Golgi. We also found that cell surfaceexposed transmembrane NRG forms retain biological activity. Thus, a mutant whose cleavage is impaired but is correctly sorted to the plasma membrane activated ErbB receptors in trans and also stimulated proliferation. Because the linker is implicated in surface sorting and the regulation of the cleavage of transmembrane NRGs, our data indicate that this region exerts multiple important roles in the physiology of NRGs.
Address correspondence to: Atanasio Pandiella (atanasio{at}usal.es)
This article has been cited by other articles:
![]() |
J. C. Montero, R. Rodriguez-Barrueco, A. Ocana, E. Diaz-Rodriguez, A. Esparis-Ogando, and A. Pandiella Neuregulins and Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3237 - 3241. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tan, Y. Wang, B. Gold, J. Chen, M. Dean, P. J. Harrison, D. R. Weinberger, and A. J. Law Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia J. Biol. Chem., August 17, 2007; 282(33): 24343 - 24351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. de Alava, A. Ocana, M. Abad, J. C. Montero, A. Esparis-Ogando, C. A. Rodriguez, A. P. Otero, T. Hernandez, J. J. Cruz, and A. Pandiella Neuregulin Expression Modulates Clinical Response to Trastuzumab in Patients With Metastatic Breast Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2656 - 2663. [Abstract] [Full Text] [PDF] |
||||